Suppr超能文献

免疫护照的科学性和伦理可行性。

The scientific and ethical feasibility of immunity passports.

机构信息

Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Department of Paediatrics, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.

出版信息

Lancet Infect Dis. 2021 Mar;21(3):e58-e63. doi: 10.1016/S1473-3099(20)30766-0. Epub 2020 Oct 16.

Abstract

There is much debate about the use of immunity passports in the response to the COVID-19 pandemic. Some have argued that immunity passports are unethical and impractical, pointing to uncertainties relating to COVID-19 immunity, issues with testing, perverse incentives, doubtful economic benefits, privacy concerns, and the risk of discriminatory effects. We first review the scientific feasibility of immunity passports. Considerable hurdles remain, but increasing understanding of the neutralising antibody response to COVID-19 might make identifying members of the community at low risk of contracting and transmitting COVID-19 possible. We respond to the ethical arguments against immunity passports and give the positive ethical arguments. First, a strong presumption should be in favour of preserving people's free movement if at all feasible. Second, failing to recognise the reduced infection threat immune individuals pose risks punishing people for low-risk behaviour. Finally, further individual and social benefits are likely to accrue from allowing people to engage in free movement. Challenges relating to the implementation of immunity passports ought to be met with targeted solutions so as to maximise their benefit.

摘要

关于在应对 COVID-19 大流行时使用免疫护照存在很多争议。一些人认为免疫护照不道德且不切实际,他们指出与 COVID-19 免疫有关的不确定性、检测问题、逆向激励、可疑的经济效益、隐私问题以及歧视性影响的风险。我们首先审查免疫护照的科学可行性。尽管仍然存在相当多的障碍,但对 COVID-19 中和抗体反应的理解不断加深,可能使确定社区中感染和传播 COVID-19 的风险较低的成员成为可能。我们回应了反对免疫护照的伦理论点,并给出了积极的伦理论点。首先,如果可行的话,应该强烈赞成保护人们的自由流动。其次,如果不承认免疫个体带来的感染风险降低,就会对低风险行为的人进行惩罚。最后,允许人们自由行动可能会带来进一步的个人和社会效益。应该针对免疫护照的实施提出有针对性的解决方案,以最大程度地发挥其益处。

相似文献

1
The scientific and ethical feasibility of immunity passports.
Lancet Infect Dis. 2021 Mar;21(3):e58-e63. doi: 10.1016/S1473-3099(20)30766-0. Epub 2020 Oct 16.
2
Passport to freedom? Immunity passports for COVID-19.
J Med Ethics. 2020 Oct;46(10):652-659. doi: 10.1136/medethics-2020-106365. Epub 2020 Aug 15.
3
Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
J Infect Dis. 2020 Aug 4;222(5):715-718. doi: 10.1093/infdis/jiaa352.
4
Implementing digital passports for SARS-CoV-2 immunization in Canada.
CMAJ. 2021 Apr 6;193(14):E486-E488. doi: 10.1503/cmaj.210244. Epub 2021 Mar 2.
5
Immunity passports, fundamental rights and public health hazards: a reply to Brown .
J Med Ethics. 2020 Oct;46(10):660-661. doi: 10.1136/medethics-2020-106814. Epub 2020 Sep 9.
6
Immunity passports to travel during the COVID-19 pandemic: controversies and public health risks.
J Public Health (Oxf). 2021 Apr 12;43(1):e135-e136. doi: 10.1093/pubmed/fdaa125.
7
Covid-19 vaccine passports: access, equity, and ethics.
BMJ. 2021 Apr 1;373:n861. doi: 10.1136/bmj.n861.
8
Antibodies as Currency: COVID-19's Golden Passport.
J Bioeth Inq. 2020 Dec;17(4):687-689. doi: 10.1007/s11673-020-09996-5. Epub 2020 Aug 25.
9
COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4108-4111. doi: 10.1080/21645515.2021.1953350. Epub 2021 Jul 22.

引用本文的文献

2
Ethical considerations of the vaccine development process and vaccination: a scoping review.
BMC Health Serv Res. 2023 Mar 14;23(1):255. doi: 10.1186/s12913-023-09237-6.
3
Vaccine Passports and Political Legitimacy: A Public Reason Framework for Policymakers.
Ethical Theory Moral Pract. 2023 Feb 15:1-21. doi: 10.1007/s10677-022-10361-1.
5
The influencing factors of digital health passport adoption and acceptance during COVID-19 in Saudi Arabia.
Digit Health. 2022 Dec 4;8:20552076221142668. doi: 10.1177/20552076221142668. eCollection 2022 Jan-Dec.
7
Effects of vaccine registration on disease prophylaxis: a systematic review.
Biomed Eng Online. 2022 Dec 3;21(1):84. doi: 10.1186/s12938-022-01053-z.
8
Public views on the Covid-19 immunity certificate: A scoping review.
Health Expect. 2022 Dec;25(6):2645-2657. doi: 10.1111/hex.13589. Epub 2022 Sep 28.

本文引用的文献

2
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.
Wellcome Open Res. 2020 Jun 11;5:139. doi: 10.12688/wellcomeopenres.15927.1. eCollection 2020.
4
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England.
EClinicalMedicine. 2020 Nov;28:100597. doi: 10.1016/j.eclinm.2020.100597. Epub 2020 Nov 6.
5
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
mBio. 2020 Oct 16;11(5):e02590-20. doi: 10.1128/mBio.02590-20.
6
Genomic evidence for reinfection with SARS-CoV-2: a case study.
Lancet Infect Dis. 2021 Jan;21(1):52-58. doi: 10.1016/S1473-3099(20)30764-7. Epub 2020 Oct 12.
7
Seasonal coronavirus protective immunity is short-lasting.
Nat Med. 2020 Nov;26(11):1691-1693. doi: 10.1038/s41591-020-1083-1. Epub 2020 Sep 14.
8
Humoral Immune Response to SARS-CoV-2 in Iceland.
N Engl J Med. 2020 Oct 29;383(18):1724-1734. doi: 10.1056/NEJMoa2026116. Epub 2020 Sep 1.
10
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
Cell Rep Med. 2020 Jun 23;1(3):100040. doi: 10.1016/j.xcrm.2020.100040. Epub 2020 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验